Abbonarsi

SEPTIC STOCK - 17/08/11

Doi : 10.1016/S0031-3955(05)70330-8 
Warick Butt *

Riassunto

Infection is problematic because it affects many patients (adults and children), is a major cause of death in ICUs worldwide, and uses a large amount of hospital resources.22, 117 The mortality rate among patients with septic shock varies but approximates 40%15, 122 in infected patients admitted to ICUs. Because of the large number of adults dying of sepsis (250,000 each year in the United States alone),153 many resources are expended. Children are physiologically different from adults, but nonetheless many similarities exist with respect to the response to septic shock.

The term systemic inflammatory response syndrome (SIRS) was proposed by the American College of Chest Physicians and Society of Critical Care Medicine to describe the nonspecific inflammatory process occurring in adults after trauma, infection, burns, pancreatitis, and other diseases. The criteria developed for use in adults16 have been modified for use in children.75 SIRS encompasses several stages of infection, from sepsis to sepsis syndrome, early septic shock, and refractory shock, which can lead to multiple organ dysfunction and death.130

Sepsis is a systemic response to infection. Evidence of bacteremia or an infective focus is not required for diagnosis. When sepsis is accompanied by altered organ perfusion, as manifested by hypoxemia, increased plasma levels of lactate, oliguria, or acute changes in mental status, sepsis syndrome is the diagnosis. Septic shock ensues when systolic blood pressure (BP) decreases to less than the fifth percentile for age. If a patient in septic shock responds promptly to parenteral fluid administration and pharmacologic treatment, he or she is diagnosed with early septic shock. Shock that lasts for more than 1 hour despite vigorous therapeutic measures and necessitates vasopressor support is refractory septic shock. Finally, the presence of impaired organ perfusion accompanied by any combination of derangements, such as disseminated intravascular coagulation; acute respiratory distress syndrome (ARDS); and acute renal, hepatic, or neurologic dysfunction, is called multiple organ dysfunction syndrome (MODS).

The natural history of SIRS in adults has been evaluated in a multicenter, prospective study of 3708 patients with infection admitted to an ICU. A total of 69% of patients developed SIRS (7% of these patients died); 20% developed sepsis (16% of these patients died); 18% developed severe sepsis (20% of these patients died); and 4% developed septic shock (46% of these patients died). A similar prospective study of 1058 children admitted to a pediatric ICU (PICU)122 showed that 82% developed SIRS, 23% developed sepsis, 4% developed severe sepsis, and 2% developed septic shock and that the overall mortality rate was 6%. In a different study, Naqvi108 showed that the sepsis syndrome occurs in less than 25% of children with documented bacteremia and that blood cultures are negative in 40% of children with sepsis. The development of shock over time markedly increases the risk for death. Among patients with sepsis in whom shock does not develop, the mortality rate is 13%; among patients in whom shock is present on hospital admission, the mortality rate is 27%; among patients in whom shock develops in the first 24 hours, the mortality rate is 43%.17

Septic shock develops in various clinical settings and is host or treatment related. Septic shock occurs in children with impaired immunity, such as neonates, or children with congenital immunodeficiencies, leukemia, cancer, or after chemotherapy. Children with congenital urinary tract abnormalities, congenital heart disease, extensive burns, or multiple trauma injuries and critically ill children with a prolonged stay in the ICU are also at increased risk. In adults and adolescents, translocation of bacteria from the gastrointestinal tract can complicate virtually any critical illness and lead to septic shock; this is less common in infants. In adults, sepsis is usually nosocomial or related to chronic disease with site-specific infections, such as abdominal sepsis, pneumonia, urinary tract infections, or infected intravascular devices. Many children with septic shock were previously healthy but develop septic shock that can be rapidly fatal. Infection with polysaccharide-escapulated organisms, such as meningococci, pneumococci, and Haemophilus influenzae, commonly is complicated by septic shock. Children less than 2 years of age who cannot make T-cell–independent antibody that is necessary to lyse polysaccharide-escapulated organisms have a predilection for infection with the earlier-mentioned organisms. The pathogens responsible for initiating septic shock in children vary with age and immunocompetence. In neonates, the primary organisms are group B β-hemolytic streptococci, Enterobacteriaceae, Listeria monocytogenes, Staphylococcus aureus, and Neisseria meningitis. In infants, the primary organisms are H. influenzae, Staphylococcus pneumoniae, S. aureus, and N. meningitis. In children, the primary organisms are S. pneumoniae, N. meningitis, S. aureus, and Enterobacteriaceae, and in immunocompromised children, the primary organisms are Enterobacteriaceae, S. aureus, Pseudomonadaceae, and Candida albicans.

It is important to diagnose the type of infection present so that rapid appropriate antibiotic therapy can be begun. Bryan23 found that, in cases in which antibiotic therapy was appropriate, 72% of 2067 patients survived compared with only 55% of 538 patients surviving after initially inappropriate therapy. The type of organism causing the infection affects prognosis. Glauser et al56 found that 57% of 257 patients with gram-negative sepsis lived, 52% of 93 patients with gram-positive sepsis lived, 17% of 9 patients with fungal sepsis lived, and 73% of 212 patients with no growth on cultures lived.

In cases in which the antibiotics given to the patient lysed the isolated microorganisms, patient prognosis was improved significantly39; however, the desire to lyse the organism quickly with large doses of antibiotics should be tempered70 with the knowledge that 4 to 6 hours after antibiotics have been given, systemic vasodilation and hypotension may occur. This occurrence is believed to be caused by the release of large amounts of toxin as a result of the antibiotics lysing large numbers of bacteria.72, 134 This condition can occur in gram-positive and gram-negative infection, and the systemic inflammatory response can be attenuated (and the shock decreased) in animals pretreated with steroids or nonsteroidal anti-inflammatory drugs.68, 75, 76 A randomized trial of dexamethasone (0.2 mg/kg) given before antibiotic treatment in 72 children with sepsis136 showed no benefit, however. Despite this study, the author still favors a single, small dose of hydrocortisone (25–50 mg) before and up to 1 hour after initiation of antibiotic therapy in patients with shock or who are likely to develop shock.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Warick Butt Pediatric Intensive Care Unit Royal Children's Hospital Flemington Road, Parkville Melbourne, VIC 3052 Australia


© 2001  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 48 - N° 3

P. 601-626 - giugno 2001 Ritorno al numero
Articolo precedente Articolo precedente
  • POINT-OF-CARE TESTING
  • Mariano R. Fiallos, Usama A. Hanhan, James P. Orlowski
| Articolo seguente Articolo seguente
  • DROWNING : Rescue, Resuscitation, and Reanimation
  • James P. Orlowski, David Szpilman

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.